She completed a general medicine research fellowship at the Massachusetts General Hospital and a MPH at the Harvard School of Public Health. Dr. Fang is the recipient of the American Heart Association Elizabeth Barrett-Connor Young Investigator Award, the California Clinician-Investigator of the Year award from the Society of General Internal Medicine, and the Milton H. Hamolsky award from the Society of General Internal Medicine. Her primary research focus is on optimizing the use of warfarin for older patients with atrial fibrillation. She is particularly interested in describing the rates, risk factors, and outcomes of extracranial and intracranial hemorrhages that occur on warfarin, and how functional decline, fall-risk, and cognitive impairment affect warfarin control and outcomes.